NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2026-03-06 • DoubleBlind Magazine

Inside the Ketamine Spoon Economy at Raves

Wearing a ketamine spoon around your neck will get you further at raves than a VIP pass. [...] Read More... The post Inside the Ketamine Spoon Economy at Raves appeared first on DoubleBlind Mag.

2026-03-06 • DoubleBlind Magazine

How to Get Your Parents Curious About Taking Mushrooms

Think your parent could benefit from psilocybin? Here’s how to talk to them—straight from those who’ve done it successfully. [...] Read More... The post How to Get Your Parents Curious About Taking Mushrooms appeared ...

2026-03-06 • Chemical Collective

The Subtle Harms of Psychedelic-Assisted Therapy and Facilitation (Part 1)

Despite its cultural prestige and rapid commercial growth, psychotherapy – as well as psychedelic-assisted therapy – rests on overstated evidence, underreported harms, and inherent power imbalances that can produce su...

2026-03-06 • Lucid News

Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation

While psychedelics have a history of sparking creativity, the first modern study to investigate the potential of psilocybin to enhance the brain’s ability to unlock creativity and problem solving is underway at the Un...

Research
2026-03-05 • Psychedelics Today

Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines

Entering the legal, regulated model of psychedelic therapy was the last thing on my mind when I moved to Colorado. I spent most of my life in rural Appalachia, bouncing from one small mountain town to the next, making...

2026-03-05 • Breaking Convention (Substack)

Trip Sitting Course off to a great start!

There's still time to join!

2026-03-04 • Psychedelic Health

Public Support for Psilocybin in the US Mirrors Early Days of Cannabis Legalisation

A study from the RAND Corporation has revealed a significant gap between the growing political momentum for psychedelic reform and actual US public opinion. The post Public Support for Psilocybin in the US Mirrors Ear...

2026-03-04 • DoubleBlind Magazine

“I Swore Off Psychedelic Retreats. Now, I’m Hosting One.”

After years of chaotic retreat experiences, one writer returns to the industry to see if it has finally grown up. [...] Read More... The post “I Swore Off Psychedelic Retreats. Now, I’m Hosting One.” appeared first on...

2026-03-04 • Chemical Collective

LSD, Music, and the Art of Listening

Oli Genn-Bash discusses how LSD uniquely enhances active listening, creativity, and musical insight, offering a more profound synergy between psychedelics and music. The post LSD, Music, and the Art of Listening appea...

2026-03-03 • Psychedelic Alpha

The State of the Psychedelic Industry & Open Questions (Video)

In the third video of a three-part series, Psychedelic Alpha’s Josh Hardman takes a look at some broader open questions and potential futures in the psychedelics field via a narrated presentation.

2026-03-03 • ICEERS

A New Stage at ICEERS: Legacy, Transition, and Continuity

In the history of an organization, there are turning points that transform more than just the organizational chart. They rearrange responsibilities, redefine priorities, and force us to review the purpose of the path ...

Community
2026-03-03 • ICEERS

Landmark Case: Coca Leaf Is Not Cocaine

A retired police officer faced charges of trafficking “cocaine” after buying coca tea online. The prosecution sought a mandatory minimum sentence of twelve years. After more than two years of proceedings and with spec...

2026-03-02 • The Microdose (Berkeley)

Minds Before Brains

An excerpt from my new book

2026-03-02 • DoubleBlind Magazine

Here’s Why Some Ayahuasca Journeys Hit Harder Than Others

PLUS, how to get your parents interested in mushrooms, eco anxiety, and Gonzo lore. [...] Read More... The post Here’s Why Some Ayahuasca Journeys Hit Harder Than Others appeared first on DoubleBlind Mag.

2026-03-02 • Psychedelic Health

FDA Grants Breakthrough Therapy Designation to The Psychedelic Luvesilocin for Postpartum Depression

The U.S. The post FDA Grants Breakthrough Therapy Designation to The Psychedelic Luvesilocin for Postpartum Depression appeared first on Psychedelic Health.

Research